Bausch & Lomb Incorporated

This study is testing a new eye drop called BL1107 to see if it is safe and effective for controlling eye pressure in adults with glaucoma or ocular hypertension. Researchers will compare two strengths of BL1107 against a standard eye drop (timolol) over 28 days. The main goal is…

This study aims to monitor the long-term safety of a specific type of artificial lens (IC-8 Apthera IOL) used in cataract surgery. It focuses on patients who have developed a common, cloudy side effect after lens implantation and have received a standard laser treatment to clear …

This study is testing a new combination eye drop (lifitegrast/perfluorohexyloctane) to see if it helps reduce the signs and symptoms of dry eye disease. About 423 adults with a history of dry eye for at least 6 months will use the drops twice daily for 4 weeks and be compared to …